Cidara Therapeutics, Inc.
Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.
CDTX | US
Overview
Corporate Details
- ISIN(s):
- US1717572069
- LEI:
- Country:
- United States of America
- Address:
- 6310 NANCY RIDGE DRIVE, 92121 SAN DIEGO
- Website:
- https://www.cidara.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Cidara Therapeutics, Inc. is a biotechnology company developing targeted immunotherapies to improve the standard of care for patients with cancer and other serious diseases, including life-threatening infections. The company utilizes its proprietary Cloudbreak® platform to design and create novel drug-Fc conjugates (DFCs). These DFCs are engineered by coupling targeted small molecules or peptides to a human antibody fragment (Fc). This approach creates therapies designed to inhibit specific disease targets while simultaneously engaging the patient's immune system for a more effective response.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cidara Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cidara Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cidara Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
